Multilingual Aspects of Signed Language Communication and Disorder

David Quinto-Pozos is an Assistant Professor in the Department of Linguistics, University of Texas at Austin, USA. His research focuses on signed language, communication disorder, language acquisition and the interaction between language and gesture in the signed modality.

• David Quinto-Pozos: Preface Laurence Leonard: Foreword 1. David Quinto-Pozos: Introduction: Considering Communication Disorders and Differences in the Signed Language Modality Part 1: Developmental Language Disorders in the Signed Modality 2. Rosalind Herman, Katherine Rowley, Chloë Marshall, Kathryn Mason, Joanna Atkinson, Bencie Woll & Gary Morgan: Profiling SLI in Deaf Children who are Sign Language Users 3. David Quinto-Pozos, Jenny Singleton, Peter Hauser, & Susan Levine: A Case-Study Approach to Investigating Developmental Signed Language Disorders 4. Aaron Shield & Richard P. Meier: The Acquisition of Sign Language by Deaf Children with Autism Spectrum Disorder 5. Wolfgang Mann & Tobias Haug: Mapping Out Guidelines for the Development and Use of Sign Language Assessments – some Critical Issues, Comments, and Suggestions Part 2: Fluency Disorders, Neurogenics and Acquired Communication Disorders 6. Geoffrey Whitebread: A Review of Stuttering in Signed Languages 7. Martha Tyrone: Sign Dysarthria: A Speech Disorder in Signed Language 8. Patricia Spanjer, Mariëlle Fieret & Anne Baker: The Influence of Dementia on Language in a Signing Population Part 3: Hearing Children from Signing Households9. Anne E. Baker and Beppie van den Bogaerde: KODAs: A Special Form of Bilingualism 10. Deborah Chen Pichler, James Lee and Diane Lillo-Martin: Language Development in ASL-English Bimodal Bilinguals

This book brings together an impressive group of contributors to present pioneering research on signed language and the manifestation of communication disorders in a visual-motor modality. Readers will undoubtedly appreciate the emphasis on bilingual considerations and the innovative recommendations for improving identification and future needs for treatment research.